Trial Profile
An Observational Study to Assess Back Pain in Patients With Severe Osteoporosis Treated With Teriparatide Versus Antiresorptives.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Bisphosphonates; Raloxifene
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 20 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 12 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.